Literature DB >> 33519942

Efficacy and Safety of Guizhi Decoction AssociatedFormulas for Allergic Rhinitis: A Systematic Review.

Shasha Yang1, Qinwei Fu2, Hua Deng1, Jing Wu3, Qinxiu Zhang2,4, Limin Wang1, Xianfeng Yao1.   

Abstract

In this study, we aim to evaluate the efficacy and safety of Guizhi Decoction associated formulas for the treatment of allergic rhinitis. A total of seven online databases were searched to collect studies published up to Feb 23rd, 2020. Study quality of each included article was evaluated by the Cochrane Collaboration risk of bias tool. Systematic reviews were conducted based on the Cochrane systematic review method by using RevMan 5.3 Software. Among the included trials, Guizhi Decoction associated formulas alone (or plus Western medicine, or acupoint-based therapy) were main therapies in experimental groups. Interventions in control groups include Western medicine, Guizhi Decoction associated formulas alone, Chinese patent medicine, and placebo control. Primary outcomes in this study include recovery rate, accumulative marked effective rate, accumulative effective rate, and recurrence rate. Finally, 23 trials involving 2281 participants were included. Results of systematic reviews show that Guizhi Decoction and associated formulas alone, plus Western medicine or plus acupoint-based therapies, were significantly better compared with using Western medicine alone in terms of efficacy. In addition, the formulas plus nasal TCM fumigation therapy could improve effective rate for AR treatment compared to using the formulas alone. More types and cases of adverse events were reported in the control groups (Western medicine alone), but events of included trials were all mild and did not need specific medical intervention. More RCTs of high quality, and large sample size, with appropriate blinding methods or nonblinded pragmatic trials of Guizhi Decoction and associated formulas for AR are needed.
Copyright © 2021 Shasha Yang et al.

Entities:  

Year:  2021        PMID: 33519942      PMCID: PMC7817259          DOI: 10.1155/2021/3548740

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


  3 in total

1.  Potential mechanisms of Guizhi decoction against hypertension based on network pharmacology and Dahl salt-sensitive rat model.

Authors:  Jiye Chen; Yongjian Zhang; Yongcheng Wang; Ping Jiang; Guofeng Zhou; Zhaoyu Li; Jinlong Yang; Xiao Li
Journal:  Chin Med       Date:  2021-04-27       Impact factor: 5.455

2.  To Predict Anti-Inflammatory and Immunomodulatory Targets of Guizhi Decoction in Treating Asthma Based on Network Pharmacology, Molecular Docking, and Experimental Validation.

Authors:  Rui Sun; Gonghao Xu; Dongyang Gao; Qi Ding; Yuanyuan Shi
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-20       Impact factor: 2.629

3.  Efficacy and Safety of Modified Yupingfeng Nasal Spray in Controlling the Recurrence of Persistent and Moderate-Severe Allergic Rhinitis: Study Protocol for a Multicenter, Open-Label, Randomized, and Parallel-Arm Trial.

Authors:  Ting Liu; Bing-Qing Lu; Dan-Dan Wang; Chao Liao; Han-Jen Chiang; Rong Zhang; Yuan Xi; Li Tian
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-10       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.